Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GLAUSER, Michel P")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2
Export

Selection :

  • and

Infectious diseases: Basel research forum internationalGLAUSER, Michel P.Drugs (Basel). 1996, Vol 52, issn 0012-6667, 114 p., SUP2Conference Proceedings

Pathophysiologic basis of sepsis : Considerations for future strategies of interventionGLAUSER, Michel P.Critical care medicine. 2000, Vol 28, Num 9, pp S4-S8, issn 0090-3493, SUPConference Paper

The appropriate use of quinolonesPERCIVAL, A.Drugs (Basel). 1996, Vol 52, pp 34-36, issn 0012-6667, SUP2Conference Paper

Antibiotic policies : Economics and effectiveness from a UK perspectiveDAVEY, P.Drugs (Basel). 1996, Vol 52, pp 83-87, issn 0012-6667, SUP2Conference Paper

Antibiotic usage : Pharmacoeconomic impact in a changing healthcare systemMILKOVICH, G.Drugs (Basel). 1996, Vol 52, pp 80-82, issn 0012-6667, SUP2Conference Paper

Antibiotic usage : Policy, clinical and pharmacoeconomic outcomesCARBON, C.Drugs (Basel). 1996, Vol 52, pp 78-79, issn 0012-6667, SUP2Conference Paper

Fluoroquinolones in urinary tract infections : Proper and improper useNABER, K. G.Drugs (Basel). 1996, Vol 52, pp 27-33, issn 0012-6667, SUP2Conference Paper

Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus. DiscussionPETERS, G; BECKER, K.Drugs (Basel). 1996, Vol 52, pp 50-54, issn 0012-6667, SUP2Conference Paper

MIF regulates innate immune responses through modulation of Toll-like receptor 4ROGER, Thierry; DAVID, John; GLAUSER, Michel P et al.Nature (London). 2001, Vol 414, Num 6866, pp 920-924, issn 0028-0836Article

Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococciENTENZA, José M; VOUILLAMOZ, Jacques; GLAUSER, Michel P et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 86-92, issn 0066-4804, 7 p.Article

The inflammatory cytokines : New developments in the pathophysiology and treatment of septic shock. DiscussionGLAUSER, M. P; DURACK, D. T.Drugs (Basel). 1996, Vol 52, pp 9-17, issn 0012-6667, SUP2Conference Paper

Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azolesMARCHETTI, Oscar; MAJCHERCZYK, Paul A; GLAUSER, Michel P et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 3, pp 696-700, issn 0066-4804Article

Pathophysiology and treatment of hepatitis C. DiscussionTHOMAS, H. C; BOOTH, J; BROWN, J et al.Drugs (Basel). 1996, Vol 52, pp 1-8, issn 0012-6667, SUP2Conference Paper

Macrophage migration inhibitory factor and innate immune responses to bacterial infectionsFROIDEVAUX, Céline; ROGER, Thierry; MARTIN, Christian et al.Critical care medicine. 2001, Vol 29, Num 7, pp S13-S15, issn 0090-3493, SUPConference Paper

Epidemiology, control and treatment of multiresistant gram-negative rods. DiscussionWIEDEMANN, B; FINCH, R. G; GLAUSER, M. P et al.Drugs (Basel). 1996, Vol 52, pp 95-102, issn 0012-6667, SUP2Conference Paper

Pitfalls in cefepime titration from human plasma: Plasma- and temperature-related drug degradation in vitroBUGNON, Denis; GIANNONI, Eric; MAJCHERCZYK, Paul et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 11, pp 3654-3656, issn 0066-4804, 3 p.Article

Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genesMARCHETTI, Oscar; MOREILLON, Philippe; ENTENZA, Josè M et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1565-1570, issn 0066-4804, 6 p.Article

New concepts in the pathophysiology and management of middle ear disease in childhood. DiscussionPELTON, S. I; KUNGU, C; GLAUSER, M. P et al.Drugs (Basel). 1996, Vol 52, pp 62-67, issn 0012-6667, SUP2Conference Paper

Epidemiology and control of multiresistant enterococci. DiscussionLECLERCQ, R; MUKHTAR, A. H; HOIBY, N et al.Drugs (Basel). 1996, Vol 52, pp 47-49, issn 0012-6667, SUP2Conference Paper

Epidemiology, control and treatment of multiresistant pneumococci. DiscussionKLUGMAN, K. P; MUKHTAR, A. H; SCHAAD, U. B et al.Drugs (Basel). 1996, Vol 52, pp 42-46, issn 0012-6667, SUP2Conference Paper

Antibiotics in sepsisBOCHUD, Pierre-Yves; GLAUSER, Michel P; CALANDRA, Thierry et al.Intensive care medicine. Supplement. 2001, Vol 27, Num 1, pp S33-S48, issn 0935-1701Article

Chronic obstructive pulmonary disease : Mortality and mortality reduction. DiscussionFIEL, S. B; PELTON, S; DURACK, D. T et al.Drugs (Basel). 1996, Vol 52, pp 55-61, issn 0012-6667, SUP2Conference Paper

Interleukin-12 : Potential clinical applications in the treatment and prevention of infectious diseases. DiscussionGATELY, M. K; MULQUEEN, M. J; DURACK, D. T et al.Drugs (Basel). 1996, Vol 52, pp 18-26, issn 0012-6667, SUP2Conference Paper

The challenge of changing healthcare systems. DiscussionWEBER, F; GLAUSER, M. P; HOIBY, N et al.Drugs (Basel). 1996, Vol 52, pp 68-77, issn 0012-6667, SUP2Conference Paper

Epidemiology, control and treatment of multidrug-resistant tuberculosisCHAULET, P; RAVIGLIONE, M; BUSTREO, F et al.Drugs (Basel). 1996, Vol 52, pp 103-108, issn 0012-6667, SUP2Conference Paper

  • Page / 2